Rishi Kumar, MD - Levetiracetam (Keppra) is an oral and intravenous antiepileptic drug (AED) indicated as adjunctive therapy for partial onset seizures, myoclonic seizures, and generalized tonic-clonic (“grand mal”) seizures in adults.
![Behavioral side-effects of levetiracetam in children with epilepsy: A systematic review - ScienceDirect Behavioral side-effects of levetiracetam in children with epilepsy: A systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S105913111400168X-gr1.jpg)
Behavioral side-effects of levetiracetam in children with epilepsy: A systematic review - ScienceDirect
![Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies | CNS Drugs Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies | CNS Drugs](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-022-00955-9/MediaObjects/40263_2022_955_Figa_HTML.png)